- FoI Number
- 2024-239
- Subject
- Speciality Waiting Times
- Date Received
- 30/07/2024
- Request and Response
-
I am writing to you under the Freedom of Information Act 2002 to request the following information from the Health board regarding referral to treatment waiting times within the following specialities.
Urology, Radiology, Trauma & Orthopaedics, ENT, Gynaecology, Gastroenterology, Ophthalmology, General Surgery, Dermatology, Pain Management/ Anaesthetics, Cardiology, Respiratory and Rheumatology.
Where the specialities listed above are defined as corresponding to the following national speciality codes.
Name Given
National Speciality Code
Urology
CB
Radiology
H1
Gastroenterology
A9
Cardiology
A2
Trauma & Orthopaedics
C8
ENT
C5
Gynaecology
F2
Ophthalmology
C7
General Surgery
C1
Dermatology
A7
Pain Management/ Anaesthetics
C31
Respiratory and Rheumatology
AQ & AR
- What percentage of patients were waiting within 18 weeks within the above specialities, as of May 2024?
As of 31/05/2024
Speciality
Waiting
Waiting Within 18 weeks
Dermatology
143
51.7%
Respiratory and Rheumatology
87
89.7%
General Surgery
595
95.3%
Pain Management/ Anaesthetics
46
100.0%
ENT
324
37.0%
Ophthalmology
294
38.8%
Trauma & Orthopaedics
188
48.9%
Gynaecology
219
85.4%
Urology
N/A
N/A
Radiology
N/A
N/A
Gastroenterology
N/A
N/A
Cardiology
N/A
N/A
Grand Total
1896
67.4%
- What percentage of patients were waiting within 18 weeks within the above specialities, as of July 2024?
As of 30/06/2024
Speciality
Waiting
Waiting Within 18 weeks
Dermatology
137
48.2%
Respiratory and Rheumatology
75
97.3%
General Surgery
572
95.1%
Pain Management/ Anaesthetics
40
100.0%
ENT
358
37.4%
Ophthalmology
310
49.7%
Trauma & Orthopaedics
163
49.7%
Gynaecology
210
82.9%
Urology
N/A
N/A
Radiology
N/A
N/A
Gastroenterology
N/A
N/A
Cardiology
N/A
N/A
Grand Total
1865
67.9%
- How many patients were waiting to start treatment within the above specialities, as of May 2024?
See response to Q1
- How many patients were waiting to start treatment within the above specialities, as of July 2024?
See response to Q2